JPH04288083A - New antibiotic MBA 028-24A substance and its manufacturing method - Google Patents
New antibiotic MBA 028-24A substance and its manufacturing methodInfo
- Publication number
- JPH04288083A JPH04288083A JP3124010A JP12401091A JPH04288083A JP H04288083 A JPH04288083 A JP H04288083A JP 3124010 A JP3124010 A JP 3124010A JP 12401091 A JP12401091 A JP 12401091A JP H04288083 A JPH04288083 A JP H04288083A
- Authority
- JP
- Japan
- Prior art keywords
- substance
- mba
- methanol
- absorption spectrum
- magnetic resonance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000126 substance Substances 0.000 title claims abstract description 33
- 230000003115 biocidal effect Effects 0.000 title claims abstract description 12
- 238000004519 manufacturing process Methods 0.000 title claims description 8
- 241000187747 Streptomyces Species 0.000 claims abstract description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 54
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 14
- 238000000862 absorption spectrum Methods 0.000 claims description 13
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 claims description 10
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 8
- 239000000843 powder Substances 0.000 claims description 8
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- CZDYPVPMEAXLPK-UHFFFAOYSA-N tetramethylsilane Chemical compound C[Si](C)(C)C CZDYPVPMEAXLPK-UHFFFAOYSA-N 0.000 claims description 6
- 238000005259 measurement Methods 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 4
- 230000009102 absorption Effects 0.000 claims description 4
- 238000010521 absorption reaction Methods 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 4
- 238000012258 culturing Methods 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- BGNGWHSBYQYVRX-UHFFFAOYSA-N 4-(dimethylamino)benzaldehyde Chemical compound CN(C)C1=CC=C(C=O)C=C1 BGNGWHSBYQYVRX-UHFFFAOYSA-N 0.000 claims description 2
- 241000186361 Actinobacteria <class> Species 0.000 claims description 2
- 229910021578 Iron(III) chloride Inorganic materials 0.000 claims description 2
- 238000006243 chemical reaction Methods 0.000 claims description 2
- 239000003153 chemical reaction reagent Substances 0.000 claims description 2
- 229910052739 hydrogen Inorganic materials 0.000 claims description 2
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 claims description 2
- 238000002844 melting Methods 0.000 claims description 2
- 230000008018 melting Effects 0.000 claims description 2
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 claims description 2
- DHRLEVQXOMLTIM-UHFFFAOYSA-N phosphoric acid;trioxomolybdenum Chemical compound O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.OP(O)(O)=O DHRLEVQXOMLTIM-UHFFFAOYSA-N 0.000 claims description 2
- 239000003814 drug Substances 0.000 abstract description 5
- 239000003905 agrochemical Substances 0.000 abstract description 4
- 230000002401 inhibitory effect Effects 0.000 abstract description 3
- 241000192125 Firmicutes Species 0.000 abstract description 2
- 229940079593 drug Drugs 0.000 abstract description 2
- 241000186046 Actinomyces Species 0.000 abstract 1
- 239000004599 antimicrobial Substances 0.000 abstract 1
- 230000001747 exhibiting effect Effects 0.000 abstract 1
- 239000002609 medium Substances 0.000 description 26
- 229920001817 Agar Polymers 0.000 description 12
- 239000008272 agar Substances 0.000 description 12
- 241000894006 Bacteria Species 0.000 description 5
- 229920002472 Starch Polymers 0.000 description 5
- 230000001580 bacterial effect Effects 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 235000019698 starch Nutrition 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 229940041514 candida albicans extract Drugs 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 239000008107 starch Substances 0.000 description 4
- 239000012138 yeast extract Substances 0.000 description 4
- 240000007817 Olea europaea Species 0.000 description 3
- 241000187391 Streptomyces hygroscopicus Species 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 210000002421 cell wall Anatomy 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000001766 physiological effect Effects 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- 241001225321 Aspergillus fumigatus Species 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 244000063299 Bacillus subtilis Species 0.000 description 2
- 235000014469 Bacillus subtilis Nutrition 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 201000007336 Cryptococcosis Diseases 0.000 description 2
- 241000221204 Cryptococcus neoformans Species 0.000 description 2
- SRBFZHDQGSBBOR-SOOFDHNKSA-N D-ribopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@@H]1O SRBFZHDQGSBBOR-SOOFDHNKSA-N 0.000 description 2
- OKKJLVBELUTLKV-MZCSYVLQSA-N Deuterated methanol Chemical compound [2H]OC([2H])([2H])[2H] OKKJLVBELUTLKV-MZCSYVLQSA-N 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 241000223221 Fusarium oxysporum Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 229910002651 NO3 Inorganic materials 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- 241000813090 Rhizoctonia solani Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 241001045770 Trichophyton mentagrophytes Species 0.000 description 2
- 238000005273 aeration Methods 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 229940091771 aspergillus fumigatus Drugs 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- OLOZVPHKXALCRI-UHFFFAOYSA-L calcium malate Chemical compound [Ca+2].[O-]C(=O)C(O)CC([O-])=O OLOZVPHKXALCRI-UHFFFAOYSA-L 0.000 description 2
- 229940016114 calcium malate Drugs 0.000 description 2
- 239000001362 calcium malate Substances 0.000 description 2
- 235000011038 calcium malates Nutrition 0.000 description 2
- 238000012136 culture method Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 229910017053 inorganic salt Inorganic materials 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 238000001819 mass spectrum Methods 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 230000000877 morphologic effect Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- 241001446247 uncultured actinomycete Species 0.000 description 2
- BBBFYZOJHSYQMW-LGDQNDJISA-N (2s)-2,4-diamino-4-oxobutanoic acid;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal Chemical compound OC(=O)[C@@H](N)CC(N)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O BBBFYZOJHSYQMW-LGDQNDJISA-N 0.000 description 1
- UQZSVIGPZAULMV-DKWTVANSSA-N (2s)-2,4-diamino-4-oxobutanoic acid;propane-1,2,3-triol Chemical compound OCC(O)CO.OC(=O)[C@@H](N)CC(N)=O UQZSVIGPZAULMV-DKWTVANSSA-N 0.000 description 1
- 241000223600 Alternaria Species 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 241000606124 Bacteroides fragilis Species 0.000 description 1
- 241000123650 Botrytis cinerea Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 229910021580 Cobalt(II) chloride Inorganic materials 0.000 description 1
- RFSUNEUAIZKAJO-VRPWFDPXSA-N D-Fructose Natural products OC[C@H]1OC(O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-VRPWFDPXSA-N 0.000 description 1
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 101000610620 Homo sapiens Putative serine protease 29 Proteins 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- GMKMEZVLHJARHF-WHFBIAKZSA-N LL-2,6-diaminopimelic acid Chemical compound OC(=O)[C@@H](N)CCC[C@H](N)C(O)=O GMKMEZVLHJARHF-WHFBIAKZSA-N 0.000 description 1
- 241001330975 Magnaporthe oryzae Species 0.000 description 1
- 241000191938 Micrococcus luteus Species 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 102100040345 Putative serine protease 29 Human genes 0.000 description 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- 101100397226 Schizosaccharomyces pombe (strain 972 / ATCC 24843) isp4 gene Proteins 0.000 description 1
- 101100397227 Schizosaccharomyces pombe (strain 972 / ATCC 24843) isp5 gene Proteins 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- PNNNRSAQSRJVSB-BXKVDMCESA-N aldehydo-L-rhamnose Chemical compound C[C@H](O)[C@H](O)[C@@H](O)[C@@H](O)C=O PNNNRSAQSRJVSB-BXKVDMCESA-N 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 238000002011 beta-particle spectroscopy Methods 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000004992 fast atom bombardment mass spectroscopy Methods 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Chemical class 0.000 description 1
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 239000006877 oatmeal agar Substances 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 238000004810 partition chromatography Methods 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 230000028070 sporulation Effects 0.000 description 1
- 239000007362 sporulation medium Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 239000013076 target substance Substances 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 239000012137 tryptone Substances 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000000273 veterinary drug Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Compounds Of Unknown Constitution (AREA)
Abstract
Description
【0001】0001
【産業上の利用分野】本発明は、新規抗生物質MBA
028−24A物質およびその製造法に関し、詳細に
は医農薬等の分野における抗菌剤として有用な新規抗生
物質MBA 028−24A物質およびその製造法に
関する。[Industrial Application Field] The present invention provides novel antibiotic MBA
The present invention relates to a substance MBA 028-24A and a method for producing the same, and more particularly to a novel antibiotic MBA 028-24A substance useful as an antibacterial agent in fields such as medicine and agrochemicals, and a method for producing the same.
【0002】0002
【従来の技術および発明が解決しようとする課題】従来
、微生物が生産する生理活性物質として数多くの抗生物
質が知られており、医薬品、動物薬、農薬等の分野で実
用化されている。しかしその一方、耐性菌の出現等の問
題が生じ、常に新規な抗生物質の出現が求められている
のが現状であった。[Prior Art and Problems to be Solved by the Invention] Conventionally, many antibiotics have been known as physiologically active substances produced by microorganisms, and have been put to practical use in the fields of pharmaceuticals, veterinary drugs, agricultural chemicals, and the like. However, on the other hand, problems such as the appearance of resistant bacteria have arisen, and the current situation is that new antibiotics are constantly being sought.
【0003】0003
【課題を解決するための手段】本発明者らは、優れた抗
菌活性を有する物質の探索を行った結果、ストレプトマ
イセス属に属するある放線菌の培養物中にかかる物質が
生産されることを見出し、本発明を完成するに至った。[Means for Solving the Problem] As a result of searching for a substance with excellent antibacterial activity, the present inventors discovered that such a substance was produced in a culture of a certain actinomycete belonging to the genus Streptomyces. They discovered this and completed the present invention.
【0004】即ち、本発明の要旨は、下記の理化学的性
質を有する新規抗生物質MBA 028−24A物質
およびその製造法に存する。
(a)物質の性状: 無色の粉末
(b)比旋光度: 〔α〕25D =+60° (c
=1.0、メタノール)
(c)融点: 130℃より徐々に着色し分解する(d
)分子量: 1082.6708(M+H)+ FAB
−MSによる
(e)紫外線吸収スペクトル: メタノール中で、次の
主な吸収を示す
λMAX nm(E1%1cm ): 240.5(3
78)、264.0(199)
(f)赤外線吸収スペクトル: 液膜法で測定した赤外
吸収スペクトルは、次の主な吸収を示す
3500〜3200、2960、2940、1700、
1640、1590、1460、1380、1240、
1140、1090、1070、1000、960 (
νcm−1)(g)1 H−核磁気共鳴スペクトル:
重メタノール中、内部標準にテトラメチルシランを使用
して測定した。次の主なケミカルシフトを示す(500
MHz)0.69(3H,d,J=7.0Hz)、0.
87(3H,d,J=7.0Hz)、0.91(3H,
d,J=6.8Hz)、0.95(3H,d,J=6.
8Hz)、1.01(3H,d,J=6.7Hz)、1
.08(3H,d,J=6.8Hz)、1.12〜1.
55(m) 、1.57(3H,s)、1.55〜1.
87(m) 、1.91(1H,m)、1.98(2H
,m)、2.06(2H,m)、2.38(1H,m)
、2.47(1H,m)、2.84(3H,s)、3.
15(2H,t,J=7.1Hz)、3.77〜3.9
4(7〜8H,m) 、4.07(1H,m)、4.2
5(1H,m)、4.73(1H,dd,J=9.0,
2.8Hz) 、5.32(1H,dd,J=14.8
,8.8Hz)、5.43(2H,m)、5.81(1
H,d,J=15.3Hz)、5.86(1H,d,J
=10.7Hz) 、6.17(1H,dd,J=14
.9,10.9Hz) 、6.19〜6.23(2H,
m)、7.18(1H,m)
(h)13C−核磁気共鳴スペクトル: 重メタノール
中、内部標準にテトラメチルシランを使用して測定した
。次の主なケミカルシフトを示す(500MHz)9.
9 、10.3、11.6、12.3、13.5、13
.7、16.8、27.9、28.3、29.7、30
.5、31.5、33.6、34.0、34.4、34
.7、38.3、41.0、41.1、41.3、41
.8、42.0、42.1、43.6、43.9、45
.1、45.2、64.8、65.3、67.2、69
.6、70.0、71.7、72.7、76.0、76
.4、79.9、80.7、99.5、120.5 、
128.1 、128.8 、130.1、132.3
、136.5 、138.4 、146.8 、14
8.8 、158.1 、168.9 、171.6
、174.0(i)溶解性: メタノール、含水アセト
ン、含水テトラヒドロフランに可溶水、アセトン、テト
ラヒドロフラン、アセトニトリル、エタノールに難溶ま
たは不溶(j)呈色反応: ドラーゲンドルフ試薬、リ
ンモリブデン酸、10%硫酸に陽性ニンヒドリン、エー
ルリッヒ試薬、塩化第二鉄に陰性
以下、本発明につき詳細に説明する。本発明の新規抗生
物質MBA 028−24A物質(以下、「MBA
028−24A物質」と略記する)は、例えばストレ
プトマイセス属に属し、下記に示す特徴および性質を有
するMBA 028−24A物質生産菌の培養液から
得ることができる。かかる生産菌としては、ストレプト
マイセス・ハイグロスコピクス(Streptmyce
s hygroscopicus)A1491(以下
、「本菌株」または「A1491株」と略記することも
ある。)が挙げられる。本菌株は、工業技術院微生物工
業技術研究所に微工研菌寄第11864号(FERM
P−11864)として寄託されている。That is, the gist of the present invention resides in a novel antibiotic MBA 028-24A substance having the following physicochemical properties and a method for producing the same. (a) Properties of substance: Colorless powder (b) Specific rotation: [α]25D = +60° (c
= 1.0, methanol) (c) Melting point: Gradually discolors and decomposes from 130°C (d
) Molecular weight: 1082.6708 (M+H)+FAB
(e) Ultraviolet absorption spectrum by -MS: λMAX nm (E1%1cm): 240.5 (3
78), 264.0 (199) (f) Infrared absorption spectrum: The infrared absorption spectrum measured by the liquid film method shows the following main absorptions: 3500-3200, 2960, 2940, 1700,
1640, 1590, 1460, 1380, 1240,
1140, 1090, 1070, 1000, 960 (
νcm-1)(g)1H-Nuclear Magnetic Resonance Spectrum:
Measurement was performed in heavy methanol using tetramethylsilane as an internal standard. The following major chemical shifts are shown (500
MHz) 0.69 (3H, d, J=7.0Hz), 0.
87 (3H, d, J = 7.0Hz), 0.91 (3H,
d, J=6.8Hz), 0.95 (3H, d, J=6.
8Hz), 1.01 (3H, d, J=6.7Hz), 1
.. 08 (3H, d, J=6.8Hz), 1.12-1.
55 (m), 1.57 (3H, s), 1.55-1.
87 (m), 1.91 (1H, m), 1.98 (2H
, m), 2.06 (2H, m), 2.38 (1H, m)
, 2.47 (1H, m), 2.84 (3H, s), 3.
15 (2H, t, J=7.1Hz), 3.77-3.9
4 (7-8H, m), 4.07 (1H, m), 4.2
5 (1H, m), 4.73 (1H, dd, J=9.0,
2.8Hz), 5.32 (1H, dd, J=14.8
, 8.8Hz), 5.43 (2H, m), 5.81 (1
H, d, J = 15.3Hz), 5.86 (1H, d, J
=10.7Hz), 6.17(1H, dd, J=14
.. 9,10.9Hz), 6.19~6.23(2H,
m), 7.18 (1H, m) (h) 13C-Nuclear Magnetic Resonance Spectrum: Measured in heavy methanol using tetramethylsilane as an internal standard. Showing the following major chemical shifts (500MHz)9.
9, 10.3, 11.6, 12.3, 13.5, 13
.. 7, 16.8, 27.9, 28.3, 29.7, 30
.. 5, 31.5, 33.6, 34.0, 34.4, 34
.. 7, 38.3, 41.0, 41.1, 41.3, 41
.. 8, 42.0, 42.1, 43.6, 43.9, 45
.. 1, 45.2, 64.8, 65.3, 67.2, 69
.. 6, 70.0, 71.7, 72.7, 76.0, 76
.. 4, 79.9, 80.7, 99.5, 120.5,
128.1, 128.8, 130.1, 132.3
, 136.5 , 138.4 , 146.8 , 14
8.8, 158.1, 168.9, 171.6
, 174.0 (i) Solubility: Soluble in methanol, aqueous acetone, aqueous tetrahydrofuran Slightly soluble or insoluble in water, acetone, tetrahydrofuran, acetonitrile, ethanol (j) Color reaction: Dragendorff reagent, phosphomolybdic acid, Positive to 10% sulfuric acid Negative to ninhydrin, Ehrlich's reagent, ferric chloride The present invention will be described in detail below. The novel antibiotic MBA 028-24A substance of the present invention (hereinafter referred to as “MBA
028-24A substance) can be obtained, for example, from a culture solution of a MBA 028-24A substance-producing bacterium that belongs to the genus Streptomyces and has the characteristics and properties shown below. Such producing bacteria include Streptomyces hygroscopicus.
s hygroscopicus) A1491 (hereinafter sometimes abbreviated as "this strain" or "A1491 strain"). This strain was submitted to the Institute of Microbial Technology, Agency of Industrial Science and Technology, with the number 11864 (FERM).
P-11864).
【0005】本菌株の形態学的特徴、各種培地上の性状
および生理学的・生物学的性状は、以下に示すとおりで
ある。
a)形態学的特徴
胞子形成培地として、スターチ・無機塩寒天培地、及び
グリセリン−アスパラギン寒天培地を用い、27℃、1
4日間培養後観察した。コロニーの色調は白〜灰色で、
時間の経過に伴って気菌糸が湿潤化し、黒味を帯びてく
る。基生菌糸は分枝して伸長し分断は見られない。胞子
鎖の形態は、多くのものは密なラセン状を示し、胞子の
分節が明瞭でない。表面構造はいぼ状(warty)〜
粗面状(rugose)を示す。[0005] The morphological characteristics, properties on various media, and physiological/biological properties of this strain are as shown below. a) Morphological characteristics Starch/inorganic salt agar medium and glycerin/asparagine agar medium were used as the sporulation medium at 27°C for 1
Observation was made after culturing for 4 days. Colony color is white to gray;
As time passes, the aerial mycelia become moist and darken. The basal hyphae branch and elongate, and no division is observed. Most of the spore chains have a dense spiral shape, and the spore segments are not clearly defined. The surface structure is warty ~
Shows a rough surface.
【0006】b)各培地上における性状ISP〔インタ
ーナショナル・ストレプトマイセス・プロジェクト(I
nternational Streptomyce
s Project)〕規定の各種培地上で27℃、
14日間培養後の性状は次に示すとおりである。以下、
Gは生育、RCは裏面の色調、AMは気菌糸、SPは可
溶性色素、Sは胞子形成に関するA1491株の性状を
示す。b) Properties on each medium ISP [International Streptomyces Project (I)
international streptomyce
s Project)] at 27°C on various specified media.
The properties after 14 days of culture are as shown below. below,
G indicates growth, RC indicates color tone of the back surface, AM indicates aerial hyphae, SP indicates soluble pigment, and S indicates properties of the A1491 strain regarding spore formation.
【0007】1)シュークロース−硝酸塩寒天培地G:
やや貧弱、白〜灰色
RC: 灰色
AM: やや貧弱、粉状、白
SP: 生成せず
S: 旺盛、密なラセン状
2)グルコース・アスパラギン寒天培地G: 中程度、
黄味白色
RC: 薄黄色
AM: やや貧弱、粉状、白
SP: 生成せず
S: 貧弱、密なラセン状
3)グリセリン・アスパラギン寒天培地(ISP5)G
: 中程度、白〜灰色、一部湿潤化
RC: 薄黄色
AM: 豊富、ビロード状〜粉状
SP: 生成せず
S: 中程度、密なラセン状
4)スターチ・無機塩寒天培地(ISP4)G: 良好
、灰〜暗い灰色
RC: 薄黄色
AM: 中程度
SP: 生成せず
S: 旺盛、密なラセン状
5)チロシン寒天培地(岡西による変法)G: 中程度
RC: 薄黄色
AM: 豊富、粉状、白
SP: 生成せず
S: 形成せず
6)普通寒天培地
G: 中程度、灰〜明るいオリーブ灰色RC: 薄黄茶
色
AM: 豊富、粉状、灰色
SP: 生成せず
S: 形成せず
7)酵母エキス・麦芽エキス寒天培地(ISP2)G:
やや貧弱、灰〜黒色、大部分湿潤化RC: 薄黄茶色
AM: 豊富、粉状、灰色
SP: 生成せず
S: かなり貧弱
8)オートミール寒天培地(ISP8)G: 中程度、
白〜明るい茶灰色
RC: 薄黄色
AM: 中程度、ビロード状、白
SP: 生成せず
S: 旺盛、密なラセン状
9)ベネット寒天培地
G: 良好、明るいオリーブ灰〜黒色、一部湿潤化RC
: 薄黄茶色
AM: 豊富、ビロード状〜粉状、明るいオリーブ灰色
SP: 生成せず
S: 旺盛、密なラセン状
10)リンゴ酸カルシウム寒天培地
G: 貧弱、黄味白色
RC: 黄味白色
AM: 極めて貧弱
SP: 生成せず
S: 形成せず
リンゴ酸カルシウムの資化能なし
C)生理学的性状
培養後1〜3週間のA1491株の生理学的性状を示す
。以下、+は陽性、−は陰性、±は疑わしいことを表わ
す。1) Sucrose-nitrate agar medium G:
Slightly poor, white to gray RC: Gray AM: Slightly weak, powdery, white SP: Not produced S: Vigorous, dense spiral 2) Glucose-asparagine agar medium G: Moderate,
Yellowish white RC: Light yellow AM: Slightly poor, powdery, white SP: Not produced S: Poor, dense spiral 3) Glycerin-asparagine agar medium (ISP5) G
: Medium, white to gray, partially moistened RC: Light yellow AM: Abundant, velvety to powdery SP: No formation S: Medium, dense spiral 4) Starch/Inorganic Salt Agar Medium (ISP4) G: Good, gray to dark gray RC: Light yellow AM: Moderate SP: Not produced S: Vigorous, dense spiral 5) Tyrosine agar medium (modified method by Okanishi) G: Moderate RC: Light yellow AM: Abundant, powdery, white SP: Not formed S: Not formed 6) Ordinary agar medium G: Medium, gray to light olive gray RC: Light yellowish brown AM: Abundant, powdery, gray SP: Not formed S : Not formed 7) Yeast extract/malt extract agar medium (ISP2) G:
Slightly poor, gray to black, mostly moist RC: Light yellowish brown AM: Abundant, powdery, gray SP: Not produced S: Fairly poor 8) Oatmeal agar medium (ISP8) G: Moderate;
White to light brown-gray RC: Light yellow AM: Medium, velvety, white SP: No formation S: Vigorous, dense spiral 9) Bennett Agar G: Good, light olive gray to black, partially moistened R.C.
: Light yellowish brown AM: Abundant, velvety to powdery, bright olive gray SP: Not produced S: Vigorous, dense spiral 10) Calcium malate agar medium G: Poor, yellowish white RC: Yellowish white AM : Extremely poor SP: Not produced S: Not formed and has no ability to assimilate calcium malate C) Physiological properties Physiological properties of the A1491 strain 1 to 3 weeks after culture are shown. Hereinafter, + means positive, - means negative, and ± means doubtful.
【0008】1)リトマスミルク
ペプトン化: +
凝固 : −
2)硝酸塩の還元: −
3)メラニン様色素の生成
PYFe培地 : −
Try−Y培地: −
チロシン培地 : −
4)デンプンの加水分解: +
5)NaCl耐性
4%: +
7%: −
10%: −
6)各種糖類からの酸の生成
D−グルコース : +
L−アラビノース : +
D−キシロース : +
D−フラクトース : +
シュークロース: +
L−ラムノース : ±
ラフィノース : +
イノシトール : +
7)生育温度範囲: 15〜45℃
注)PTFe培地 : ペプトン、酵母エキス、鉄寒
天培地Try−Y培地: トリプトン、酵母エキス寒天
培地d)菌体成分について
本菌株A1491株の細胞壁アミノ酸タイプは、全菌体
水解物の分析によりL,L−ジアミノピメリン酸が検出
されたことから、細胞壁タイプI型であることが確認さ
れた。また、細胞壁糖組成についても全菌体水解物中か
らグルコース及びリボースが検出されたが、特徴的なパ
ターンは認められなかった。1) Litmus milk peptonization: + Coagulation: - 2) Reduction of nitrate: - 3) Production of melanin-like pigments PYFe medium: - Try-Y medium: - Tyrosine medium: - 4) Hydrolysis of starch: + 5) NaCl tolerance 4%: + 7%: - 10%: - 6) Production of acids from various sugars D-glucose: + L-arabinose: + D-xylose: + D-fructose: + Sucrose: + L -Rhamnose: ± Raffinose: + Inositol: + 7) Growth temperature range: 15 to 45°C Note) PTFe medium: Peptone, yeast extract, iron agar medium Try-Y medium: Tryptone, yeast extract agar medium d) Regarding bacterial components The cell wall amino acid type of the present strain A1491 was confirmed to be cell wall type I, since L,L-diaminopimelic acid was detected by analysis of whole cell hydrolyzate. Regarding the cell wall sugar composition, glucose and ribose were detected in the whole cell hydrolyzate, but no characteristic pattern was observed.
【0009】e)分類学的考察
本菌株A1491株は、コロニー色調が培養初期には白
〜灰褐色を呈し、培養が古くなるとコロニーの所々に黒
斑状の斑点ができ、それが次第に広がって全体が黒い湿
潤状態になる。メラニン色素は産生せず。胞子形成様式
は密なラセン状(spiral)を示す。胞子表面はい
ぼ状(warty)〜粗面状(rugose)を示す。
上記の諸性状からA1491株はStreptomyc
es属に属する放線菌であることは明らかである。e) Taxonomic considerations The colony color of this strain A1491 is white to grayish-brown at the early stage of culture, and as the culture gets older, black spots appear here and there on the colony, which gradually spreads and forms the entire colony. becomes black and wet. Does not produce melanin pigment. The sporulation mode shows a dense spiral. The spore surface is warty to rough. Based on the above properties, the A1491 strain is Streptomyces
It is clear that it is an actinomycete belonging to the genus es.
【0010】A1491株の示す諸性状をもつ菌種をB
ergey’s Manual第8版、ISP(In
ternational Journal of
Systematic Bacteriology
、第22巻、307〜311ページ、1972年)記載
及び他の文献の中から検索した結果、最も近縁の種とし
てStreptomyces hygroscopi
cusが挙げられた。[0010] Bacterial species with the properties shown by A1491 strain were
ergey's Manual 8th Edition, ISP (In
International Journal of
Systematic Bacteriology
, Vol. 22, pp. 307-311, 1972) and other literature, we found that Streptomyces hygroscopici is the most closely related species.
Cus was mentioned.
【0011】Streptomyces hygro
scopicusは1)気菌糸先端にラセン状の胞子鎖
を形成する、胞子表面はいぼ状〜粗面状を呈する、2)
灰褐色の気菌糸を着生する、3)気菌糸が培養後期に湿
潤化し黒斑状になるなど3点の大きな特徴を持つ。[0011] Streptomyces hygro
Scopicus 1) forms a helical spore chain at the tip of the aerial hyphae, and the spore surface is warty to rough; 2)
It has three major characteristics: it grows gray-brown aerial mycelium, and 3) the aerial mycelium becomes moist in the later stages of cultivation and becomes black-spotted.
【0012】以上述べたごとく、A1491株はISP
記載のStreptomyceshygroscopi
cusとよく一致しておりStreptomyces
hygroscopicusと同定し、本菌株をSt
reptomyces hygroscopicus
A1491と命名した。[0012] As stated above, the A1491 strain is ISP
Streptomyceshygroscopy described
cus and Streptomyces
The strain was identified as St. hygroscopicus.
reptomyces hygroscopicus
It was named A1491.
【0013】なお、本発明においては、A1491株の
みに限定されるものではなく、上記のような新規抗生物
質MBA 028−24A物質を生産する能力を有す
るものはすべて用いることができる。本発明においては
、前記の菌を通常の微生物が利用しうる栄養源を含有す
る培地で培養する。この培地は放線菌が利用できる栄養
源を含む培地であればよく、培地の組成分として、糖類
、澱粉類、グリセリンの如き同化性炭素源、コーンスチ
ープリカー、酵母エキス、肉エキス、ペプトン、アンモ
ニウム塩の如き有機または無機窒素源を含有できる。ま
た、リン酸塩類、カルシウム、鉄等の金属塩類等を含有
することもできる。その他、必要に応じてシリコーン、
植物油、または合成消泡剤を培地に添加してもよい。[0013] The present invention is not limited to the A1491 strain, but any strain capable of producing the above-mentioned novel antibiotic MBA 028-24A substance can be used. In the present invention, the above-mentioned bacteria are cultured in a medium containing a nutrient source that can be used by ordinary microorganisms. This medium may be any medium containing nutritional sources that can be used by actinomycetes, and its components include sugars, starches, assimilable carbon sources such as glycerin, corn steep liquor, yeast extract, meat extract, peptone, and ammonium. Organic or inorganic nitrogen sources such as salts can be included. Moreover, phosphates, metal salts such as calcium, iron, etc. can also be contained. In addition, silicone as needed.
Vegetable oils or synthetic antifoaming agents may be added to the medium.
【0014】培養法としては、好気的条件下での培養法
が適している。培養に適当な温度は10〜30℃である
が、多くの場合、20〜27℃で培養する。本発明のM
BA028−24A物質の生産は培地や培養条件により
異なるが、振とう培養、タンク培養とも通常3〜10日
間でその蓄積が最高に達する。[0014] As a culture method, a culture method under aerobic conditions is suitable. The appropriate temperature for culturing is 10 to 30°C, but in many cases, culture is carried out at 20 to 27°C. M of the present invention
The production of BA028-24A substance varies depending on the medium and culture conditions, but the accumulation usually reaches its maximum within 3 to 10 days in both shaking culture and tank culture.
【0015】培養物中の蓄積量が最高になった時に培養
を停止し、培養液から目的物質を単離精製する。本発明
のMBA 028−24A物質は培養液中から通常用
いられる手段を適宜に利用して採取し得る。たとえば、
MBA 028−24A物質と不純物との溶解度差を
利用する手段、吸着親和力の差を利用する手段、イオン
結合力の差を利用する手段を単独または組合せで、ある
いは反復して利用し得る。[0015] When the amount accumulated in the culture reaches the maximum, the culture is stopped, and the target substance is isolated and purified from the culture solution. The MBA 028-24A substance of the present invention can be collected from the culture solution using any commonly used means. for example,
Means utilizing the solubility difference between the MBA 028-24A substance and the impurity, means utilizing the difference in adsorption affinity, and means utilizing the difference in ionic binding force may be used alone or in combination, or repeatedly.
【0016】[0016]
【実施例】以下に本発明を実施例によってさらに詳細に
説明するが、本発明はその要旨を超えない限り以下の実
施例によって限定されるものではない。EXAMPLES The present invention will be explained in more detail with reference to examples below, but the present invention is not limited to the following examples unless it exceeds the gist thereof.
【0017】(実施例1)水アメ 4.0%、大豆油
0.3%、大豆粉 2.0%、ファーマメディア
1.0%、サングレイン 0.5%、CaCO3 0
.3%、FeSO4 ・7H2 O 0.0001%
、CoCl2 ・6H2 O 0.00001%、N
iCl2 0.00001%を含有する培地80ml(
pH7.0)を500ml三角フラスコに分注し、滅菌
後、ストレプトミセス・ハイグロスコピクスA1491
株を接種し、27℃で96時間、210回転にて振とう
培養した。上記と同様の組成からなる培地20l(pH
7.0)を含む30lジャーファ−メンターに前記培養
液200mlを接種し、27℃で96時間通気攪拌培養
(20l/分通気、200rpm)を行った。ついで培
養液を採取し、培養液から菌体を濾別した。得られた菌
体に4lのアセトンを加え、充分浸漬し、攪拌後抽出液
を濾別した。この抽出液を蒸留水を加えて7lに調整し
、これを予め60%メタノールで飽和、調整したHP−
20カラム(約1l)の上部に充てんした。60%メタ
ノールで洗浄後、メタノールで活性成分を溶出した。得
られた活性画分を集め、溶媒を減圧下に留去して粗粉末
21gを得た。(Example 1) Starch syrup 4.0%, soybean oil 0.3%, soybean flour 2.0%, Pharmamedia 1.0%, sungrain 0.5%, CaCO3 0
.. 3%, FeSO4 ・7H2 O 0.0001%
, CoCl2 ・6H2 O 0.00001%, N
80 ml of medium containing 0.00001% iCl2 (
Dispense the solution (pH 7.0) into a 500 ml Erlenmeyer flask, sterilize it, and add Streptomyces hygroscopicus A1491.
The strain was inoculated and cultured with shaking at 210 rpm for 96 hours at 27°C. 20 liters of medium with the same composition as above (pH
200 ml of the above culture solution was inoculated into a 30 liter jar fermenter containing 7.0), and cultured with aeration (20 liter/min aeration, 200 rpm) at 27° C. for 96 hours. Then, the culture solution was collected, and the bacterial cells were filtered out from the culture solution. 4 liters of acetone was added to the obtained bacterial cells, and the cells were thoroughly immersed, stirred, and the extract was filtered. Distilled water was added to this extract to adjust the volume to 7 liters, and this was saturated with 60% methanol beforehand.
The top of 20 columns (approximately 1 liter) was packed. After washing with 60% methanol, the active ingredient was eluted with methanol. The obtained active fractions were collected and the solvent was distilled off under reduced pressure to obtain 21 g of crude powder.
【0018】(実施例2)実施例1の粗粉末をさらに精
製するために、この粗粉末10gを60%メタノールに
溶解し60%メタノールから100%メタノールのグラ
ジエント溶出でODS−シリカゲル(山村科学社製、O
DS−AQ 120−S50)による逆相分配クロマ
トグラフィーを行い活性画分を集めた。この活性画分の
溶媒を減圧下に留去して、淡黄色の粗粉末5gを得た。
この粉末をメタノール−水混液(85: 15)を展開
溶媒とする逆相分配高速液体クロマトグラフィー Y
MC−D−ODS−5カラム(山村科学社製、30×2
50mm)に付し、MBA 028−24A物質を含
む画分を得、これらの画分の溶媒をそれぞれ減圧下に留
去して、MBA 028−24A物質の粉末約0.8
gを得た。(Example 2) In order to further purify the crude powder of Example 1, 10 g of this crude powder was dissolved in 60% methanol, and ODS-silica gel (Yamamura Kagakusha Co., Ltd.) was eluted with a gradient from 60% methanol to 100% methanol. Manufactured by O
Reverse phase partition chromatography was performed using DS-AQ 120-S50) and active fractions were collected. The solvent of this active fraction was distilled off under reduced pressure to obtain 5 g of pale yellow crude powder. This powder was subjected to reverse phase partition high performance liquid chromatography using a methanol-water mixture (85:15) as a developing solvent.
MC-D-ODS-5 column (manufactured by Yamamura Kagaku Co., Ltd., 30×2
50 mm) to obtain fractions containing the MBA 028-24A substance, and the solvent of each of these fractions was distilled off under reduced pressure to obtain a powder of about 0.8 mm of the MBA 028-24A substance.
I got g.
【0019】MBA 028−24A物質のUV吸収
スペクトル、IR吸収スペクトル1H−核磁気共鳴スペ
クトル、13C−核磁気共鳴スペクトル、マススペクト
ルの測定結果は次の通りであった。The measurement results of the UV absorption spectrum, IR absorption spectrum, 1H-nuclear magnetic resonance spectrum, 13C-nuclear magnetic resonance spectrum, and mass spectrum of the MBA 028-24A substance were as follows.
【0020】■UV吸収スペクトル: 図1に示すよう
に240.5nm及び264.0nmに特徴的な吸収を
示す。■UV absorption spectrum: As shown in FIG. 1, it exhibits characteristic absorption at 240.5 nm and 264.0 nm.
【0021】■IR吸収スペクトル: 図2に示すよう
に液膜法で測定したIR吸収スペクトルは次の主な吸収
を示す。■IR absorption spectrum: As shown in FIG. 2, the IR absorption spectrum measured by the liquid film method shows the following main absorptions.
【0022】νcm−1: 3500〜3200、29
60、2940、1700、1640、1590、14
60、1380、1240、1140、1090、10
70、1000、960
■1H−核磁気共鳴スペクトル: 重メタノール中、内
部標準にテトラメチルシランを使用して測定した結果を
、図3に示す。次の主なケミカルシフトを示す(500
MHz)[0022] νcm-1: 3500-3200, 29
60, 2940, 1700, 1640, 1590, 14
60, 1380, 1240, 1140, 1090, 10
70, 1000, 960 (1) 1H-Nuclear Magnetic Resonance Spectrum: The results of measurement in heavy methanol using tetramethylsilane as an internal standard are shown in FIG. The following major chemical shifts are shown (500
MHz)
【0023】0.69(3H,d,J=7.0
Hz)、0.87(3H,d,J=7.0Hz)、0.
91(3H,d,J=6.8Hz)、0.95(3H,
d,J=6.8Hz)、1.01(3H,d,J=6.
7Hz)、1.08(3H,d,J=6.8Hz)、1
.12〜1.55(m) 、1.57(3H,s)、1
.55〜1.87(m) 、1.91(1H,m)、1
.98(2H,m)、2.06(2H,m)、2.38
(1H,m)、2.47(1H,m)、2.84(3H
,s)、3.15(2H,t,J=7.1Hz)、3.
77〜3.94(7〜8H,m) 、4.07(1H,
m)、4.25(1H,m)、4.73(1H,dd,
J=9.0,2.8Hz) 、5.32(1H,dd,
J=14.8,8.8Hz)、5.43(2H,m)、
5.81(1H,d,J=15.3Hz) 、5.86
(1H,d,J=10.7Hz) 、6.17(1H,
dd,J=14.9,10.9Hz) 、6.19〜6
.23(2H,m)、7.18(1H,m)■13C−
核磁気共鳴スペクトル: 重メタノール中、内部標準に
テトラメチルシランを使用して測定した結果を図4に示
す。次の主なケミカルシフトを示す(500MHz)0.69 (3H, d, J=7.0
Hz), 0.87 (3H, d, J=7.0Hz), 0.
91 (3H, d, J = 6.8Hz), 0.95 (3H,
d, J=6.8Hz), 1.01 (3H, d, J=6.
7Hz), 1.08 (3H, d, J=6.8Hz), 1
.. 12-1.55 (m), 1.57 (3H, s), 1
.. 55-1.87 (m), 1.91 (1H, m), 1
.. 98 (2H, m), 2.06 (2H, m), 2.38
(1H, m), 2.47 (1H, m), 2.84 (3H
, s), 3.15 (2H, t, J=7.1Hz), 3.
77-3.94 (7-8H, m), 4.07 (1H,
m), 4.25 (1H, m), 4.73 (1H, dd,
J=9.0, 2.8Hz), 5.32(1H, dd,
J=14.8, 8.8Hz), 5.43 (2H, m),
5.81 (1H, d, J = 15.3Hz), 5.86
(1H, d, J=10.7Hz), 6.17 (1H,
dd, J=14.9, 10.9Hz), 6.19~6
.. 23 (2H, m), 7.18 (1H, m) ■13C-
Nuclear magnetic resonance spectrum: The results of measurement in heavy methanol using tetramethylsilane as an internal standard are shown in FIG. Shows the following major chemical shifts (500MHz)
【
0024】9.9 、10.3、11.6、12.3、
13.5、13.7、16.8、27.9、28.3、
29.7、30.5、31.5、33.6、34.0、
34.4、34.7、38.3、41.0、41.1、
41.3、41.8、42.0、42.1、43.6、
43.9、45.1、45.2、64.8、65.3、
67.2、69.6、70.0、71.7、72.7、
76.0、76.4、79.9、80.7、99.5、
120.5 、128.1 、128.8 、130.
1、132.3 、136.5 、138.4 、14
6.8 、148.8 、158.1 、168.9
、171.6 、174.0
■マススペクトル: 高分解能 FAB−MS(Fa
st Atom Bombardment Ma
ss Spectrometry)により測定したと
ころ、1082.6708(M+H)+ であった。[
9.9, 10.3, 11.6, 12.3,
13.5, 13.7, 16.8, 27.9, 28.3,
29.7, 30.5, 31.5, 33.6, 34.0,
34.4, 34.7, 38.3, 41.0, 41.1,
41.3, 41.8, 42.0, 42.1, 43.6,
43.9, 45.1, 45.2, 64.8, 65.3,
67.2, 69.6, 70.0, 71.7, 72.7,
76.0, 76.4, 79.9, 80.7, 99.5,
120.5, 128.1, 128.8, 130.
1, 132.3, 136.5, 138.4, 14
6.8, 148.8, 158.1, 168.9
, 171.6, 174.0 ■Mass spectrum: High resolution FAB-MS (Fa
st Atom Bombardment Ma
When measured by SS Spectrometry, it was 1082.6708 (M+H)+.
【0025】なお、MBA 028−24A物質の構
造解析を行ったところ、下記式で表される化合物である
ことが確認された。[0025] When the MBA 028-24A substance was structurally analyzed, it was confirmed that it was a compound represented by the following formula.
【0026】[0026]
【化1】[Chemical formula 1]
【0027】(上記式中、R1およびR2の一方は−C
OCH2COOHを表し、他方は水素原子を表す)(実
施例3)日本化学療法学会標準法に従い、各試験菌に対
する実施例で得たMBA 028−24A物質の最小
生育阻止濃度(mcg/ml)を求め、これを以下に示
す。(In the above formula, one of R1 and R2 is -C
OCH2COOH, and the other represents a hydrogen atom) (Example 3) According to the Japanese Society of Chemotherapy standard method, determine the minimum growth inhibitory concentration (mcg/ml) of the MBA 028-24A substance obtained in the example for each test bacterium. , which is shown below.
【0028】Bacillus subtilis (
バチルス・ズブチリス): 3.1
Sarcina lutea (サルシナ・ルテア):
3.1Staphylococcus aureus
209P: 1.56(スタフィロコッカス・アウレ
ウス209P)
Bacteroides fragilis(バクテロ
イデス・フラギリス): 6.2
Escherichia coli (エスケリチア・
コリ): >100Pseudomonas aeru
ginosa(シュードモナス・エルギノーザ): >
100
Cryptococcus neoformans (
クリプトコッカス・ネオホルマンス): 1.56
Trichophyton mentagrophyt
es (トリコフィトン・メンタグロフィテス): 3
.1
Candida albicans(カンジダ・アルビ
カンス): 3.1Aspergillus fumi
gatus (アスペルギルス・フミガタス): 3.
1
Alternaria porri(アルタナリア・ポ
リ): 3.1Fusarium oxysporum
(フザリウム・オキシスポラム): 12.5
Botrytis cinerea(ボトリチス・シネ
リア): 0.78Piricularia oryz
ae(ピリキュラリア・オリゼ): 0.78
Rhizoctonia solani(リゾクトニア
・ソラニ):0.78[0028] Bacillus subtilis (
Bacillus subtilis): 3.1 Sarcina lutea:
3.1 Staphylococcus aureus
209P: 1.56 (Staphylococcus aureus 209P) Bacteroides fragilis: 6.2 Escherichia coli (Escherichia coli)
Cori): >100Pseudomonas aeru
ginosa (Pseudomonas aeruginosa): >
100 Cryptococcus neoformans (
Cryptococcus neoformans): 1.56 Trichophyton mentagrophyt
es (Trichophyton mentagrophytes): 3. 1 Candida albicans: 3.1 Aspergillus fumi
gatus (Aspergillus fumigatus): 3.
1 Alternaria pori: 3.1 Fusarium oxysporum
(Fusarium oxysporum): 12.5 Botrytis cinerea: 0.78 Piricularia oryz
ae (Pyricularia oryzae): 0.78 Rhizoctonia solani (Rhizoctonia solani): 0.78
【0029】[0029]
【発明の効果】本発明で得られる抗生物質はグラム陽性
菌、糸状菌に対して強い生育阻止力を示し、例えば細菌
および真菌感染症の治療剤、植物病害防除剤などの医薬
、農薬の活性成分として有用である。Effects of the Invention The antibiotic obtained by the present invention exhibits a strong growth-inhibiting ability against Gram-positive bacteria and filamentous fungi, and has a high activity in medicines such as therapeutic agents for bacterial and fungal infections, plant disease control agents, and agricultural chemicals. Useful as an ingredient.
【図1】MBA 028−24A物質の紫外部吸収ス
ペクトル(メタノール中)を示す図面である。FIG. 1 shows the ultraviolet absorption spectrum (in methanol) of the MBA 028-24A material.
【図2】MBA 028−24A物質の液膜法で測定
した赤外部吸収スペクトルを示す図面である。FIG. 2 is a drawing showing an infrared absorption spectrum of MBA 028-24A substance measured by a liquid film method.
【図3】MBA 028−24A物質の1 H−核磁
気共鳴スペクトル(500MHz、重メタノール中)を
示す図面である。FIG. 3 shows the 1 H-nuclear magnetic resonance spectrum (500 MHz, in heavy methanol) of the MBA 028-24A material.
【図4】MBA 028−24A物質の13C−核磁
気共鳴スペクトル(500MHz、重メタノール中)を
示す図面である。FIG. 4 shows the 13C-nuclear magnetic resonance spectrum (500 MHz, in deuterated methanol) of the MBA 028-24A material.
Claims (2)
物質MBA 028−24A物質。 (a)物質の性状: 無色の粉末 (b)比旋光度: 〔α〕25D =+60℃ (c
=1.0、メタノール) (c)融点: 130℃より徐々に着色し分解する(d
)分子量: 1082.6708(M+H)+ FAB
−MSによる (e)紫外線吸収スペクトル: メタノール中で、次の
主な吸収を示す λMAX nm(E1%1cm ): 240.5(3
78)、264.0(199) (f)赤外線吸収スペクトル: 液膜法で測定した赤外
吸収スペクトルは、次の主な吸収を示す 3500〜3200、2960、2940、1700、
1640、1590、1460、1380、1240、
1140、1090、1070、1000、960 (
νcm−1)(g)1 H−核磁気共鳴スペクトル:
重メタノール中、内部標準にテトラメチルシランを使用
して測定した。次の主なケミカルシフトを示す(500
MHz)0.69(3H,d,J=7.0Hz)、0.
87(3H,d,J=7.0Hz)、0.91(3H,
d,J=6.8Hz)、0.95(3H,d,J=6.
8Hz)、1.01(3H,d,J=6.7Hz)、1
.08(3H,d,J=6.8Hz)、1.12〜1.
55(m) 、1.57(3H,s)、1.55〜1.
87(m) 、1.91(1H,m)、1.98(2H
,m)、2.06(2H,m)、2.38(1H,m)
、2.47(1H,m)、2.84(3H,s)、3.
15(2H,t,J=7.1Hz)、3.77〜3.9
4(7〜8H,m) 、4.07(1H,m)、4.2
5(1H,m)、4.73(1H,dd,J=9.0,
2.8Hz) 、5.32(1H,dd,J=14.8
,8.8Hz)、5.43(2H,m)、5.81(1
H,d,J=15.3Hz)、5.86(1H,d,J
=10.7Hz) 、6.17(1H,dd,J=14
.9,10.9Hz) 、6.19〜6.23(2H,
m)、7.18(1H,m) (h)13C−核磁気共鳴スペクトル: 重メタノール
中、内部標準にテトラメチルシランを使用して測定した
。次の主なケミカルシフトを示す(500MHz)9.
9 、10.3、11.6、12.3、13.5、13
.7、16.8、27.9、28.3、29.7、30
.5、31.5、33.6、34.0、34.4、34
.7、38.3、41.0、41.1、41.3、41
.8、42.0、42.1、43.6、43.9、45
.1、45.2、64.8、65.3、67.2、69
.6、70.0、71.7、72.7、76.0、76
.4、79.9、80.7、99.5、120.5 、
128.1 、128.8 、130.1、132.3
、136.5 、138.4 、146.8 、14
8.8 、158.1 、168.9 、171.6
、174.0(i)溶解性: メタノール、含水アセト
ン、含水テトラヒドロフランに可溶水、アセトン、テト
ラヒドロフラン、アセトニトリル、エタノールに難溶ま
たは不溶(j)呈色反応: ドラーゲンドルフ試薬、リ
ンモリブデン酸、10%硫酸に陽性ニンヒドリン、エー
ルリッヒ試薬、塩化第二鉄に陰性Claim 1: A novel antibiotic MBA 028-24A substance having the following physicochemical properties. (a) Properties of substance: Colorless powder (b) Specific rotation: [α]25D = +60℃ (c
= 1.0, methanol) (c) Melting point: Gradually discolors and decomposes from 130°C (d
) Molecular weight: 1082.6708 (M+H)+FAB
(e) Ultraviolet absorption spectrum by -MS: λMAX nm (E1%1cm): 240.5 (3
78), 264.0 (199) (f) Infrared absorption spectrum: The infrared absorption spectrum measured by the liquid film method shows the following main absorptions: 3500-3200, 2960, 2940, 1700,
1640, 1590, 1460, 1380, 1240,
1140, 1090, 1070, 1000, 960 (
νcm-1)(g)1H-Nuclear Magnetic Resonance Spectrum:
Measurement was performed in heavy methanol using tetramethylsilane as an internal standard. The following major chemical shifts are shown (500
MHz) 0.69 (3H, d, J=7.0Hz), 0.
87 (3H, d, J = 7.0Hz), 0.91 (3H,
d, J=6.8Hz), 0.95 (3H, d, J=6.
8Hz), 1.01 (3H, d, J=6.7Hz), 1
.. 08 (3H, d, J=6.8Hz), 1.12-1.
55 (m), 1.57 (3H, s), 1.55-1.
87 (m), 1.91 (1H, m), 1.98 (2H
, m), 2.06 (2H, m), 2.38 (1H, m)
, 2.47 (1H, m), 2.84 (3H, s), 3.
15 (2H, t, J=7.1Hz), 3.77-3.9
4 (7-8H, m), 4.07 (1H, m), 4.2
5 (1H, m), 4.73 (1H, dd, J=9.0,
2.8Hz), 5.32 (1H, dd, J=14.8
, 8.8Hz), 5.43 (2H, m), 5.81 (1
H, d, J = 15.3Hz), 5.86 (1H, d, J
=10.7Hz), 6.17(1H, dd, J=14
.. 9,10.9Hz), 6.19~6.23(2H,
m), 7.18 (1H, m) (h) 13C-Nuclear Magnetic Resonance Spectrum: Measured in heavy methanol using tetramethylsilane as an internal standard. Showing the following major chemical shifts (500MHz)9.
9, 10.3, 11.6, 12.3, 13.5, 13
.. 7, 16.8, 27.9, 28.3, 29.7, 30
.. 5, 31.5, 33.6, 34.0, 34.4, 34
.. 7, 38.3, 41.0, 41.1, 41.3, 41
.. 8, 42.0, 42.1, 43.6, 43.9, 45
.. 1, 45.2, 64.8, 65.3, 67.2, 69
.. 6, 70.0, 71.7, 72.7, 76.0, 76
.. 4, 79.9, 80.7, 99.5, 120.5,
128.1, 128.8, 130.1, 132.3
, 136.5 , 138.4 , 146.8 , 14
8.8, 158.1, 168.9, 171.6
, 174.0 (i) Solubility: Soluble in methanol, aqueous acetone, aqueous tetrahydrofuran Slightly soluble or insoluble in water, acetone, tetrahydrofuran, acetonitrile, ethanol (j) Color reaction: Dragendorff reagent, phosphomolybdic acid, Positive to 10% sulfuric acid, negative to ninhydrin, Ehrlich's reagent, ferric chloride
を培養し、その培養物から請求項1記載の抗生物質MB
A 028−24A物質を採取することを特徴とする
新規抗生物質MBA 028−24A物質の製造法。[Claim 2] The antibiotic MB according to Claim 1 is obtained by culturing actinomycetes belonging to the genus Streptomyces and using the cultured product.
A method for producing a novel antibiotic MBA 028-24A substance, which comprises collecting the A 028-24A substance.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3124010A JPH04288083A (en) | 1991-01-17 | 1991-05-28 | New antibiotic MBA 028-24A substance and its manufacturing method |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP398491 | 1991-01-17 | ||
JP3-3984 | 1991-02-15 | ||
JP3124010A JPH04288083A (en) | 1991-01-17 | 1991-05-28 | New antibiotic MBA 028-24A substance and its manufacturing method |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH04288083A true JPH04288083A (en) | 1992-10-13 |
Family
ID=26337669
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP3124010A Pending JPH04288083A (en) | 1991-01-17 | 1991-05-28 | New antibiotic MBA 028-24A substance and its manufacturing method |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH04288083A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1048496C (en) * | 1995-03-13 | 2000-01-19 | 中国医学科学院医药生物技术研究所 | Antibiotic Polaramycin A, B and preparation method thereof |
-
1991
- 1991-05-28 JP JP3124010A patent/JPH04288083A/en active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1048496C (en) * | 1995-03-13 | 2000-01-19 | 中国医学科学院医药生物技术研究所 | Antibiotic Polaramycin A, B and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Miyairi et al. | Enterocin, a new antibiotic taxonomy, isolation and characterization | |
US4107297A (en) | Antibiotic compound | |
Itoh et al. | Isolation, physicochemical properties and biological activities of amicoumacins produced by Bacillus pumilus | |
Hayashi et al. | WS9326A, A NOVEL TACHYKININ ANTAGONIST ISOLATED FROM Streptomyces violaceusniger No. 9326 I. TAXONOMY, FERMENTATION, ISOLATION, PHYSICO-CHEMICAL PROPERTIES AND BIOLOGICAL ACTIVITIES | |
JPS61268187A (en) | Novel antibiotic substance sk-1071 and production thereof | |
Kanda et al. | DB-2073, A new alkylresorcinol antibiotic I. Taxonomy, isolation and characterization | |
KONISHI et al. | Empedopeptin (BMY-28117), A new depsipeptide antibiotic I. Production, isolation and properties | |
Itoh et al. | Studies on antibiotics BN-227 and BN-227-F, new antibiotics I. Taxonomy, isolation and characterization | |
Yamashita et al. | L-1, 4-CYCL0HEXADIENE-1-ALANINE, AN ANTAGONIST OF PHENYLALANINE, FROM STREPTOMYCES | |
JPH04288083A (en) | New antibiotic MBA 028-24A substance and its manufacturing method | |
US4623733A (en) | Antimicrobial peptide | |
US4332902A (en) | Antibiotic substance | |
JPH04281794A (en) | New antibiotic MBA 028-24B substance and its manufacturing method | |
JPS5823077B2 (en) | Antibiotic AM-3603 and its manufacturing method | |
CA1152915A (en) | Antibiotics c-14482 b.sub.1, b.sub.2 and b.sub.3 | |
US4588822A (en) | Physiologically active substances SS 12538, their preparation and a novel microorganism producing same | |
US4194064A (en) | Production of nanaomycin B | |
US4512976A (en) | Antibiotic stubomycin and process for the production thereof | |
KR850000099B1 (en) | Method of Preparation SEN-143 Compound | |
JPH06234784A (en) | New antibiotic sf 2768 substance and its production | |
US4308210A (en) | Nanaomycin B and therapeutic compositions containing same | |
CA1077421A (en) | Antibiotic sf-1540 from streptomyces | |
JPH05310766A (en) | Novel antibiotic MI481-42F4-A and method for producing the same | |
Haroun | Isolation and characterization of NRCS-15, a new iron-containing antibiotic | |
JP3256265B2 (en) | Novel antibiotic RS-28A, method for producing the same and fungicide for agricultural and horticultural use |